back to company universe
Other

Darmiyan

Novel quantitative virtual microscopy for early detection of Alzheimer's disease from non-invasive MRI.

sources
1
Evidence entries preserved.
affiliations
1
Y Combinator
competitors
6
Mapped from High Signal graph features.
status
generated
D1 lookup
last updated
2026-07-15
16:41 UTC
source evidence
Why this company exists here

Y Combinator

yc-company-directory #1230

Novel quantitative virtual microscopy for early detection of Alzheimer's disease from non-invasive MRI.

source
generated read
High Signal interpretation

Darmiyan is classified as Other from source descriptions and fund-directory context. Similar companies below are ranked from offline product facets and meaningful description overlap; category and source affiliation can only strengthen an existing product match. For lookup-created rows, the profile starts as pending enrichment until deeper source collection runs.

offline extraction
Product facets
non-invasive MRINovel quantitative virtual microscopy
mapping method
Similarity graph

Local clusters rerank extracted product concepts and description terms. The generated graph remains the fallback for sparse descriptions: offline reciprocal product-similarity graph: extracted concepts + description terms + bounded category/affiliation boosts. Minimum fallback score: 0; max competitors: 6.

discovery cluster

Companies similar to Darmiyan

Other · 6 peers

A deterministic local cluster built from offline product facets and meaningful description terms. Category and selected-institution affiliation provide bounded tie-breaks. Open any peer to continue exploring its cluster.

Actipulse Neuroscience

match 53

Non-invasive brain stimulation is a widely-utilized, FDA cleared treatment used for patients diagnosed with depression, but is limited to a hospital setting due to the cost of the device, and complexity of treatment application. Our proprietary brain stimulation device allows patients to be treated directly from their home, with the same efficacy, and at a lower cost of treatment. Currently in FDA pivotal phase for Major Depressive Disorder, and Pilot phase for Alzheimer's and Parkinson diseases

shared extracted concept terms: non, invasive; shared product terms: non, invasive, alzheimer, disease; shared affiliation: Y Combinator

CranioSense

match 36

CranioSense is developing an accurate, non-invasive sensing platform that enables rapid triage and diagnosis of elevated brain pressure to minimize time to treatment.

shared extracted concept terms: non, invasive; shared product terms: non, invasive

Luminist Labs

match 33

Luminist developed a non-invasive diagnostic test for the early detection and staging of liver fibrosis and non-alcoholic steatohepatitis (NASH). Luminist was acquired in 2020 by DiscernDx.

shared product terms: early, detection, non, invasive; shared affiliation: Y Combinator

Entelexo Biotherapeutics

match 27

Entelexo is creating modern treatments for immune-mediated diseases, such as psoriasis, using novel engineered exosome technology.

shared extracted concept terms: novel; shared product terms: novel, disease; shared affiliation: Y Combinator

Biocartesian

match 27

Finding new cures requires seeing what and where the abnormal molecules are in a diseased tissue, but current tools see less than 1% of those molecules. Biocartesian combines microscopy and new chemistries to see 50X more, offering unprecedented insights into disease biology and new therapies.

shared extracted concept terms: microscopy; shared product terms: microscopy, disease; shared affiliation: Y Combinator

Motley Bio

match 24

Early disease profiling & detection with multiomic sequencing.

shared product terms: early, detection, disease